CSW Industrials Inc. (CSW)
NYSE: CSW
· Real-Time Price · USD
265.91
1.83 (0.69%)
At close: Sep 04, 2025, 3:59 PM
265.95
0.02%
After-hours: Sep 04, 2025, 05:50 PM EDT
CSW Industrials Revenue Breakdown
| Period Ending | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Industrial Products Revenue | 46.83M | 37.91M | 48.49M | 53.26M | 41.61M | 31.71M | 41.86M | 43.48M | 73.91M | 28.5M | 36.19M |
| Industrial Products Revenue Growth | +23.54% | -21.82% | -8.96% | +28.01% | +31.19% | -24.23% | -3.72% | -41.18% | +159.35% | -21.25% | n/a |
| Specialty Chemicals Revenue | 66.71M | 31.13M | 20.51M | 21.38M | 19.15M | 19.89M | 15.24M | 17.19M | 37.08M | 18.07M | 19.77M |
| Specialty Chemicals Revenue Growth | +114.30% | +51.75% | -4.06% | +11.67% | -3.74% | +30.47% | -11.30% | -53.65% | +105.17% | -8.58% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
|---|---|---|---|
| Non-Us Revenue | 35.79M | 12.22M | 13.88M |
| Non-Us Revenue Growth | +192.88% | -11.99% | n/a |
| United States Revenue | 129.38M | 58.7M | 69.86M |
| United States Revenue Growth | +120.42% | -15.98% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 60.57M | 56.84M | 50.51M | 52.35M | 51.66M | 49.3M | 46.4M | 48.97M | 46.96M | 45.58M | 42.69M | 45.33M | 45.55M | 43.41M | 37.89M | 37.16M | 40.12M | 37.05M | 35.22M | 26.56M | 26.5M | 28.63M | 27.2M | 27.28M | 26.91M | 26.77M | 24.81M | 25M | 24.34M | 25.66M | 21.92M | 26.83M | 28.11M | 26.13M | 25.5M | 25.89M | 29.71M | 30.87M | 25.18M | 19.42M | 24.92M | 20.85M |
| Selling, General, and Administrative Revenue Growth | +6.56% | +12.53% | -3.52% | +1.34% | +4.79% | +6.25% | -5.24% | +4.27% | +3.03% | +6.78% | -5.83% | -0.49% | +4.95% | +14.54% | +1.98% | -7.39% | +8.29% | +5.20% | +32.63% | +0.22% | -7.46% | +5.26% | -0.29% | +1.37% | +0.52% | +7.93% | -0.79% | +2.72% | -5.12% | +17.03% | -18.29% | -4.54% | +7.55% | +2.46% | -1.51% | -12.85% | -3.74% | +22.58% | +29.69% | -22.07% | +19.50% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 5.9M | n/a | n/a | n/a | 4.8M | n/a | n/a | n/a | 4.8M | n/a | n/a | n/a | 4.5M | n/a | n/a | n/a | 4.3M | n/a | n/a | n/a | 4.3M | n/a | n/a | n/a | 4.6M | n/a | n/a | n/a | 4.8M | n/a | n/a | n/a | 4.5M | 1.35M | 649K | 1.24M | 1.44M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | +234.32% | +107.40% | -47.66% | -13.71% | n/a |